FierceHealthcareFierceHealthITFierceHealthFinanceFierceEMRHospital ImpactFierceMobileHealthcare   FiercePharma

Study: Doctors largely support commercial funding for CME

Tools
Tags
Stanford University
pharmaceutical industry
medical devicemakers
Manhattan Research
Continuing Medical Education
Congress

The healthcare industry may be in an uproar over pharma and medical devicemaker funding for physician activities, but physicians don't seem to be so conflicted, if a recent study is to be believed.

The study, by Manhattan Research, concludes that only 9 percent of U.S. doctors are against commercial support for continuing medical education, and that only 8 percent of physicians who participate in CME believe it's biased. Half of the physicians surveyed by Manhattan Research told researchers that they'd decrease their use of CME if commercial support was halted.

Commercial funding for CME continues to be under challenge within institutions, however. (For example, last summer Stanford University set tough limits on pharmaceutical industry financing of CME there.) Meanwhile, Congress has continued to pressure pharmas and devicemakers to voluntarily disclose CME funding.

To learn more about this research:
- read this press release

Related Articles:
Senate investigates pharma influence on CME
Case study: NY hospital drops pharma CME funding
SPOTLIGHT: Pharma's influence in continuing medical education
Doctors weigh in on the pros and cons of accepting drug/device freebies

Bookmark and Share
Get Your FREE FierceHealthcare Email Newsletter:
Be the first to comment

Comments

Post new comment

The content of this field is kept private and will not be shown publicly.

More information about formatting options

To combat spam, please enter the code in the image.